Search for: "BRISTOL MYERS SQUIBB"
Results 501 - 520
of 866
Sorted by Relevance
|
Sort by Date
25 Apr 2010, 5:52 pm
Bristol-Myers Squibb Co. [read post]
30 Jun 2016, 12:12 pm
Non-clinical studies have demonstrated reversal of all approved NOACs including Daiichi Sankyo's SavaysaTM/Lixiana® (edoxaban), Boehringer Ingelheim's Pradaxa® (dabigatran etexilate), Johnson & Johnson and Bayer's Xarelto® (rivaroxaban), and Bristol-Myers Squibb and Pfizer's Eliquis® (apixaban). [read post]
10 Aug 2016, 5:23 pm
On August 5, 2016, a shareholder filed a derivative lawsuit in New York (New York County) Supreme Court against Bristol-Myers Squibb, as nominal defendant, and the company’s board of directors. [read post]
28 Jul 2011, 3:33 pm
(4) The Court of Justice is requested to clarify whether it is only the risk that the consumer/end user might be misled into assuming that the trade mark proprietor is responsible for the repackaging which is of significance in answering Question 1, or whether other considerations regarding the trade mark proprietor are also relevant, for example (a) that the entity which undertakes the importation and physical repackaging and (re)affixes the trade mark proprietor’s trade… [read post]
15 Dec 2020, 5:00 am
Supreme Court opinions, the most recent of which was in the case of Bristol-Myers Squibb v. [read post]
28 Jul 2013, 9:29 am
Byetta, now sold by Bristol-Myers Squibb and AstraZeneca, was approved in 2005 and contained a warning about pancreatitis. [read post]
28 Aug 2014, 12:26 pm
Eliquis (apixaban) is jointly manufactured by Pfizer and Bristol-Myers Squibb (BMS), and approved for prevention of strokes among patients with atrial fibrillation. [read post]
23 Jan 2023, 4:02 am
In October, 2014 Jenkins filed a lawsuit for damages against Bristol-Myers Squibb Company and Otsuka American Pharmaceutical Inc., the makers of Abilify. [read post]
2 Nov 2006, 9:50 pm
District Court for the Southern District of New York granted a preliminary injunction to Sanofi-Synthelabo and Bristol-Myers Squibb in their patent infringement case against Apotex. [read post]
7 Jan 2014, 5:19 pm
Onglyza (saxagliptin) was approved by the FDA in 2009 and is manufactured by Bristol-Myers Squibb and AstraZeneca. [read post]
30 Jul 2013, 1:34 pm
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
20 Sep 2011, 3:52 am
" But "the current ProPublica database does not include a number of drug makers, including Roche and Bristol Myers Squibb. [read post]
27 Apr 2017, 4:20 am
” On Tuesday, the court heard argument in Bristol-Myers Squibb Co. v. [read post]
27 Feb 2010, 6:24 am
Cir. 1992); Bristol-Myers Squibb Co. v. [read post]
22 Jul 2010, 7:10 am
" The group of drugs under concern include some of the top-selling blood pressure drugs, such as Cozaar, which is manufactured by Merck, and Avapro, a Bristol-Myers Squibb drug. [read post]
30 Jul 2013, 1:34 pm
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
19 Oct 2009, 6:40 am
The conference will feature distinguished speakers from such companies as DuPont, Wal-Mart, American Airlines, Intel, Microsoft, Google, Bristol-Myers Squibb, NBC Universal, GE, Wyeth Pharmaceuticals, Prudential, Freddie Mac, Verizon and many others! [read post]
15 Dec 2011, 9:00 pm
The new venture is in collaboration with Bristol-Myers Squibb, DuPont and Pfizer. [read post]
22 Aug 2012, 6:09 am
Drug companies including Pfizer, Merck & Co. and Bristol Myers-Squibb Co. are squeezed by rising research costs, the weak global economy and pressure from Europe, China and elsewhere to reduce drug prices. [read post]
3 Apr 2009, 4:50 am
: Scinopharm Taiwan Ltd v Eli Lily & Co (PatLit) Naglazyme (Galsulfase) - Brazil: Federal Court of the First Region orders government to supply unapproved drug Naglazyme (IP tango) Plavix (Clopidogrel) – US: Bristol-Myers Squibb to pay $2.1 million to settle FTC claims it issues misleading statement about proposed Plavix patent deal with Apotex, violating court orders from earlier anti-trust cases (Law360) Razadyne (Galantamine) – US: Johnson… [read post]
